121 related articles for article (PubMed ID: 35831998)
21. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of preoperative peripheral blood neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase-to-platelet ratio index in patients with hepatitis B virus related intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(38):3134-3140. PubMed ID: 34674423
[No Abstract] [Full Text] [Related]
25. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
Lv M; Wang K; Zhang Z; Zhang Z; Wan J
Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
27. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
28. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
[TBL] [Abstract][Full Text] [Related]
29. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm.
Jan HC; Hu CY; Yang WH; Ou CH
Clin Genitourin Cancer; 2020 Aug; 18(4):e484-e500. PubMed ID: 32199741
[TBL] [Abstract][Full Text] [Related]
30. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Liguori C; Copparoni C; Felicetti C; Pecci F; Lupi A; Pinterpe G; Berardi R; Giampieri R
Curr Oncol; 2023 Jan; 30(1):1032-1045. PubMed ID: 36661728
[TBL] [Abstract][Full Text] [Related]
33. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis.
Tsilimigras DI; Moris D; Mehta R; Paredes AZ; Sahara K; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
HPB (Oxford); 2020 Dec; 22(12):1667-1674. PubMed ID: 32265108
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
36. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.
Cui H; Li Y; Li S; Liu G
Cancer Med; 2023 Jan; 12(1):99-110. PubMed ID: 35692190
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
[TBL] [Abstract][Full Text] [Related]
38. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
39. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
[TBL] [Abstract][Full Text] [Related]
40. The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.
Muzykiewicz KP; Iwanska E; Janeczek M; Glanowska I; Karolewski K; Blecharz P
Ginekol Pol; 2021; 92(1):16-23. PubMed ID: 33448001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
